INCY Earnings & Financial Statements
Incyte Corporation
$111.57
+$2.95(+2.72%)
58
Overall
80
Value
27
Tech
68
Quality
Market Cap
$22.61B
Volume
1.87M
52W Range
$82.82 - $132.60
Target Price
$130.36
INCY earnings and financial statements: Incyte Corporation's income statement, balance sheet and cash flow statement, annual and quarterly.
INCY Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $5.14B | $4.24B | $3.70B | $3.39B | $2.99B |
| Cost of revenue | $372.13M | $312.07M | $254.99M | $207.00M | $150.99M |
| Operating income | $1.51B | $61.37M | $620.52M | $579.44M | $585.78M |
| EBITDA | $1.76B | $408.16M | $919.43M | $599.64M | $630.20M |
| Net income | $1.29B | $32.62M | $597.60M | $340.66M | $948.58M |
| EPS (diluted) | $6.41 | $0.15 | $2.65 | $1.52 | $4.27 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $6.96B | $5.44B | $6.78B | $5.84B | $4.93B |
| Total liabilities | $1.79B | $2.00B | $1.59B | $1.47B | $1.16B |
| Shareholders’ equity | $5.17B | $3.45B | $5.19B | $4.37B | $3.77B |
| Cash and equivalents | $3.10B | $1.69B | $3.21B | $2.95B | $2.06B |
| Long-term debt | $30.20M | $33.54M | $29.16M | $30.08M | $31.63M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $1.41B | $335.34M | $496.49M | $969.94M | $749.49M |
| Capital expenditure | -$83.87M | -$100.16M | -$47.49M | -$77.83M | -$181.01M |
| Free cash flow | $1.33B | $235.17M | $449.00M | $892.11M | $568.48M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INCY | $111.57 | +2.7% | 1.87M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |